Winch Advisory Services LLC lifted its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 19.4% in the 2nd quarter, Holdings Channel.com reports. The firm owned 419 shares of the healthcare conglomerate’s stock after purchasing an additional 68 shares during the period. Winch Advisory Services LLC’s holdings in UnitedHealth Group were worth $102,000 as of its most recent SEC filing.
Other institutional investors have also recently added to or reduced their stakes in the company. Patriot Financial Group Insurance Agency LLC lifted its position in UnitedHealth Group by 88.4% in the second quarter. Patriot Financial Group Insurance Agency LLC now owns 356 shares of the healthcare conglomerate’s stock valued at $87,000 after acquiring an additional 167 shares during the last quarter. Van ECK Associates Corp lifted its position in UnitedHealth Group by 648.6% in the second quarter. Van ECK Associates Corp now owns 141,147 shares of the healthcare conglomerate’s stock valued at $34,441,000 after acquiring an additional 122,293 shares during the last quarter. Beacon Investment Advisory Services Inc. lifted its position in UnitedHealth Group by 0.4% in the second quarter. Beacon Investment Advisory Services Inc. now owns 45,605 shares of the healthcare conglomerate’s stock valued at $11,128,000 after acquiring an additional 184 shares during the last quarter. Mitsubishi UFJ Trust & Banking Corp lifted its position in UnitedHealth Group by 3.7% in the second quarter. Mitsubishi UFJ Trust & Banking Corp now owns 955,364 shares of the healthcare conglomerate’s stock valued at $235,344,000 after acquiring an additional 33,947 shares during the last quarter. Finally, Pillar Pacific Capital Management LLC purchased a new stake in UnitedHealth Group in the second quarter valued at $201,000. 85.37% of the stock is owned by institutional investors and hedge funds.
In other news, Director Richard T. Burke sold 10,000 shares of the business’s stock in a transaction dated Wednesday, May 29th. The shares were sold at an average price of $241.99, for a total transaction of $2,419,900.00. Following the transaction, the director now directly owns 187,663 shares in the company, valued at $45,412,569.37. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director William C. Ballard, Jr. sold 12,000 shares of the business’s stock in a transaction dated Tuesday, July 23rd. The stock was sold at an average price of $255.31, for a total transaction of $3,063,720.00. Following the transaction, the director now owns 61,309 shares in the company, valued at $15,652,800.79. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 37,000 shares of company stock worth $9,195,620. Company insiders own 0.87% of the company’s stock.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.46 by $0.14. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The business had revenue of $60.60 billion for the quarter, compared to analyst estimates of $60.59 billion. During the same period in the previous year, the business posted $3.14 earnings per share. The business’s revenue was up 8.0% compared to the same quarter last year. As a group, sell-side analysts forecast that UnitedHealth Group Inc will post 14.84 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be paid a dividend of $1.08 per share. The ex-dividend date is Friday, September 13th. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.87%. UnitedHealth Group’s dividend payout ratio (DPR) is 33.54%.
A number of brokerages recently weighed in on UNH. Citigroup raised shares of UnitedHealth Group from a “neutral” rating to a “buy” rating and boosted their price target for the company from $247.00 to $280.00 in a research report on Friday, May 10th. Morgan Stanley boosted their price target on shares of UnitedHealth Group from $285.00 to $298.00 and gave the company an “overweight” rating in a research report on Friday, July 12th. Cleveland Research reissued a “buy” rating on shares of UnitedHealth Group in a research report on Monday, July 15th. Cantor Fitzgerald set a $310.00 price objective on shares of UnitedHealth Group and gave the company a “buy” rating in a research note on Friday, July 19th. Finally, Oppenheimer set a $312.00 price objective on shares of UnitedHealth Group and gave the company a “buy” rating in a research note on Friday, July 19th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and eighteen have given a buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $295.06.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: What is Green Investing?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.